BBI Life Sciences

What BBI Life Sciences does

BBI Life Sciences is the Hong Kong–incorporated holding company of the BBI Group, a China-rooted provider of life sciences research products and services headquartered in the Songjiang District of Shanghai. The Group traces its operating history to Shanghai Sangon Biological Engineering Technology & Services Co., Ltd. (SSBETS), incorporated in 2001, with the listed holding vehicle formed in 2014 and subsequently privatized via a scheme of arrangement in 2020 (previously HKEX ticker 01035). The Group operates a four-pillar catalogue: (i) DNA synthesis products based on solid-phase phosphoramidite chemistry, with daily output of over 10,000 oligonucleotides (~200,000 bases) covering multiple purification grades (desalting, PAGE, affinity, HPLC); (ii) genetic engineering services spanning Sanger/capillary sequencing, next-generation sequencing, and molecular biology workflows (gene cloning, genotyping, gene expression analysis, real-time PCR); (iii) life sciences research consumables (biochemical reagents, kits, and labware such as pipettes, centrifuge tubes, cell culture, and PCR consumables); and (iv) protein and antibody products (prokaryotic and yeast expression, recombinant purification via standard chromatography, custom polyclonal and monoclonal antibody production, with a disclosed catalogue exceeding 12,000 antibody types as of June 2017).

The commercial model is primarily a one-time product sale channel (DNA synthesis, consumables, protein/antibody) combined with professional services revenue (sequencing and molecular biology work) and custom production services (antibody, protein expression). Customers are diversified across academic and research institutions (colleges, universities, and research institutes), biotechnology and pharmaceutical companies, hospitals and medical institutions — with 68.1% of H1 2017 revenue from colleges, universities, research institutes, and biotech/medicine customers. Distribution is handled through wholly- and majority-owned subsidiaries across the value chain: Sangon Biotech (PRC operations), Bio Basic and Bio Basic Canada (North America/Asia-Pacific), NBS Biologicals (UK/Europe), Bionics (Korea), and KleanAB, supported by the Group's direct sales force and a stated global distribution footprint covering roughly 40 countries across North America, Europe, Asia Pacific, Latin America, the Middle East, Africa, and Oceania. The company has actively pursued vertical and clinical expansion — including 2016 capital injections into Shanghai Youlong Biotech (portfolio extension) and Tianjin Hengjia (clinical medical field) — and reported passing four Chinese Ministry of Health external proficiency tests with its Sangon health medical testing laboratory in 2019.

Name

BBI Life Sciences

Legal name

BBI Life Sciences Co., Ltd.

Website

https://bbi-lifesciences.com

Company type

Private

Founded year

2014

Operating status

Acquired

Headcount range

1,001–5,000 employees

Short description

BBI Life Sciences is a Shanghai-headquartered, formerly Hong Kong-listed provider of life sciences research products and services — DNA synthesis, genetic engineering/sequencing, lab consumables, and custom protein/antibody production — serving universities, research institutes, biotech/pharma companies, and hospitals across roughly 40 countries via wholly-owned subsidiaries including Sangon Biotech, Bio Basic, NBS Biologicals, and Bionics.

Ownership category

akta.pro rank

Product category

Life Sciences Research Products and Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

Keywords

• DNA synthesis products
• Life sciences research
• Genetic engineering services
• Protein antibody production
• Oligonucleotide gene synthesis

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. DNA Synthesis Products: Revenue from oligonucleotide synthesis and gene synthesis products - the fundamental building blocks needed for life sciences research projects.
2. Genetic Engineering Services: DNA sequencing, next-generation sequencing, and molecular biology services including gene cloning, genotyping, gene expression analysis, and real-time PCR.
3. Life Sciences Research Consumables: Biochemical reagents, research kits, and labware products sold to research laboratories.
4. Protein and Antibody Products and Services: Protein related products including polypeptides, protein extraction and analysis kits, and antibody products and services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

BBI Life Sciences manufactures and supplies life sciences research products and services across four lines: DNA Synthesis Products (custom oligonucleotide and gene synthesis), Genetic Engineering Services (Sanger and next-generation DNA sequencing plus molecular biology services), Life Sciences Research Consumables (biochemical reagents, research kits, and labware), and Protein and Antibody Related Products (polypeptides, protein expression/purification kits, and custom polyclonal and monoclonal antibody production). The offerings are sold to universities, research institutes, biotechnology companies, pharmaceutical companies, and hospitals through direct sales and a global distribution network spanning China and overseas markets.

Product overview

BBI Life Sciences offers a comprehensive portfolio of four interconnected product and service lines for life sciences research: (1) DNA Synthesis Products covering oligonucleotide and gene synthesis; (2) Genetic Engineering Services including DNA sequencing, next-generation sequencing, and molecular biology services; (3) Life Sciences Research Consumables comprising biochemical reagents, research kits, and labware; and (4) Protein and Antibody Related Products for protein expression, purification, and custom antibody production. Together, these offerings serve the complete workflow of life sciences research from gene synthesis through protein production and analysis.

Differentiator

Problem solved

Functional benefit

Brands

• Sangon Biotech: DNA synthesis and life sciences research products and services subsidiary
• Bio Basic
• KleanAB
• NBS Biologicals
• Bionics

Products and services

• DNA Synthesis Products Custom oligonucleotide and gene synthesis products synthesized using solid-phase phosphoramidite methods, with capacity of 10,000+ oligonucleotides (~200,000 bases) per day. Offers multiple purification methods including desalting, PAGE, affinity, and HPLC purification. Includes patented gene synthesis for genes containing repetitive sequences and fluorescent clone screening vector technology.
• Genetic Engineering Services Comprehensive genetic engineering services covering DNA sequencing (Sanger/capillary electrophoresis and next-generation sequencing) and molecular biology services including gene cloning, genotyping, gene expression analysis, and real-time PCR.
• Life Sciences Research Consumables Experimental materials and consumables including biochemical reagents, research kits, and labware such as pipettes, centrifuge tubes, cell culture products, and PCR tubes and plates for life sciences laboratories.
• Protein and Antibody Related Products Products and services for protein and antibody production, detection, and analysis including polypeptides, protein extraction and analysis kits, protein expression (prokaryotic and yeast systems), purification services using mainstream chromatography, and custom polyclonal and monoclonal antibody production. The company has developed over 12,000 types of antibodies.

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core subsidiary, regional expansion and product line.

• Sangon Biotechcore subsidiaryOthersPrimary operating subsidiary of BBI Group in China, providing DNA synthesis and other life sciences products and services. Located in Shanghai.
• Bio Basiccore subsidiaryOthersInternational subsidiary providing life sciences research products and services in overseas markets including North America and Asia Pacific.
• NBS Biologicalsregional expansionOthersUK-based subsidiary acquired by BBI to expand into the European market.
• Bionicsregional expansionOthersSouth Korean subsidiary (70% ownership) providing life sciences products and services in the Korean market.
• KleanABproduct lineOthersSubsidiary website under BBI Group focused on specific product lines.

Scale indicators3 records

Recent moves12 records

Expansion highlights4 records

Direct peers

• GenScript: China-headquartered competitor offering gene synthesis, oligonucleotide synthesis, protein/antibody production and related life-sciences research services — closely overlaps BBI's DNA synthesis and antibody product lines and targets a similar academic/biotech customer base.
• Eurofins Genomics: Subsidiary of Eurofins Scientific providing DNA sequencing, oligonucleotide synthesis, gene synthesis and genotyping services — competes with BBI's genetic engineering services and DNA sequencing business globally.
• Twist Bioscience: US-based DNA synthesis leader using silicon-based synthesis at scale, offering synthetic genes, oligo pools and NGS target enrichment; competes head-to-head with BBI's Sangon subsidiary in the gene- and oligo-synthesis product category.
• Synbio Technologies: China-based gene synthesis and molecular biology services provider with overlapping product lines in gene synthesis, DNA sequencing and recombinant protein expression — a direct Sangon/BBI competitor.
• Beijing Tsingke Biotech: Domestic Chinese competitor specializing in DNA synthesis, gene synthesis and related molecular biology services — directly overlaps BBI's core Sangon Biotech offerings in the China life-sciences research tools market.
• Integrated DNA Technologies (IDT): Now part of Danaher, IDT is a leading global supplier of custom oligonucleotides, NGS adapters and qPCR reagents — directly comparable to BBI's oligonucleotide synthesis and molecular biology service lines.
• Macrogen: Korea-headquartered DNA sequencing and gene synthesis services provider — directly comparable to BBI's Sanger/NGS sequencing and gene synthesis offerings across the Asian market.

Broad incumbents

• Bio-Rad Laboratories: Established life-sciences research products manufacturer covering reagents, antibodies, life-science instrumentation and consumables — broader portfolio but overlapping with BBI's consumables, antibody and molecular biology reagent lines.
• Agilent Technologies: Large global life-sciences instrumentation and reagent supplier with meaningful exposure to genomics, PCR/qPCR reagents and nucleic acid analysis tools; a broad incumbent competitor to BBI's research consumables and sequencing-adjacent offerings.
• Thermo Fisher Scientific: Global life-sciences tools and CRO giant spanning reagents, antibodies, custom DNA/RNA oligos and NGS services — a broad incumbent whose catalog scales overlap BBI's four product lines from consumables to antibody production.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bbi-life-sciences-corp

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries13 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BBI Life Sciences